Professor of Pediatrics, University of Pennsylvania School of Medicine
- Department: Pediatrics
- Division: Oncology
- Primary Address:
34th & CIVIC CENTER
Philadelphia, PA 19104
- Professor of Pediatrics at the Children's Hospital of Philadelphia (2006 – present)
- Associate Professor of Pediatrics at the Children's Hospital of Philadelphia (1994 – 2006)
- Assistant Professor of Pediatrics at the Children's Hospital of Philadelphia (1991 – 1994)
- Assistant Professor of Pediatrics, University of Pennsylvania School of Medicine (1985 – 1991)
- M.D., University of Rochester (1978)
- B.A., Biology, University of Rochester (1974)
I specialize in sarcomas, which are cancers of connective tissues (such as bones, muscles and tendons). I coordinate the evaluation of patients with sarcomas, supervise their chemotherapy and coordinate their treatment with surgeons, radiation oncologists and other specialists. I am the senior member of our sarcoma team, which has three physicians and a nurse practitioner.
When dealing with complicated diseases like sarcomas, it is important to take the time to do things right. Treating sarcomas involves lots of scans, tests, medicines and consultations with other professionals -- and families can find the process confusing and overwhelming. Many sarcoma patients are teenagers who are just beginning to gain their freedom, only to lose a lot of it as they become cancer patients. That is why it is important that I understand the patient and family, and that they understand what we are doing and why. We work to make the patient and family active participants in treatment.
I also specialize in medication and chemotherapy safety. Working closely with other physicians, nurses, pharmacists, computer specialists and others, I try to make the complex process of ordering and administering chemotherapy and other medicines as straightforward and safe as possible, both in the Cancer Center and in the hospital as a whole.
My research involves the development of sarcoma studies through the Children's Oncology Group, the world's largest childhood cancer research organization. I also work with biology researchers who are trying to combine clinical and biologic data to understand and treat sarcomas better.
At The Children's Hospital of Philadelphia, we are fortunate to have people who study every variety of pediatric cancer in depth. Whether it's sarcoma or another cancer, there is someone in our division who is an expert and focuses their research on it -- and who knows other experts around the world. We also have nurses, child life specialists, nutritionists, social workers, physical therapists and others who specialize in treating children with cancer. That is a huge advantage for patients and families, and helps make CHOP a wonderful place to work.
- Hill-Kayser CE, Bagatell R, Reilly A, Womer R, Balamuth N, Both S, Lustig R, Tochner Z. Outcomes after proton therapy for pediatric patients with cancers of the head and neck region. American Society for Radiation Oncology Annual Meeting. 2013 May.
- Hill-Kayser CE, Tochner Z, Both S, Lustig R, Reilly A, Balamuth NJ, Womer RB, Maris JM, Grupp S, Bagatell R. Proton versus photon radiation therapy for patients with high-risk neuroblastoma: The need for a customized approach. Pediatric Blood and Cancer. 2013:in press.
- Weiss AR, Lyden ER, Anderson JR, Hawkins DS, Spunt SL, Walterhouse DO, Wolden SL, Parham DM, Rodeberg DA, Kao SC, Womer RB. Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: A report from the Children's Oncology Group.. Journal of Clinical Oncology. 2013:in press.
- DuBois SG, Krailo M, Gebhardt M, Donaldson S, Marcus KJ, Dormans J, Shamberger RC, Sailer S, Nicholas R, Healey J, Tarbell N, Devidas M, Meyer J, Granowetter L, Womer RB, Bernstein M, Marina N, Grier HE. Local and distant failure according to mode of local control in patients with localized Ewing sarcoma of bone: A report from the Children?s Oncology Group. Connective Tissue Oncology Society Annual Meeting, Prague, CZ. 2012 November.
- Albritton K, Krailo M, Marina NM, Granowetter L, Grier HE, Womer RB, Janeway KA, Najera SL, Gorlick RG. Older age as an independent prognostic factor in Ewing sarcoma treated on Children?s Oncology Group protocols. Connective Tissue Oncology Society Annual Meeting. 2012 November.
- DuBois SG, Krailo M, Gebhardt M, Donaldson S, Marcus KJ, Dormans J, Shamberger RC, Sailer S, Nicholas R, Healey J, Tarbell N, Devidas M, Meyer J, Granowetter L, Womer RB, Bernstein M, Marina N, Grier HE. Local control strategies in patients with localized Ewing sarcoma of bone: A report from the Children's Oncology Group. American Society of Clinical Oncology Annual Meeting, Chicago, IL. 2012 June.
- Kopp L, Bernstein M, Schwartz C, Ebb D, Krailo M, Grier H, Meyers P, Wexler L, Marina N, Womer R, Janeway K, Gorlick R, Lipschultz SE. The effects of dexrazoxane on cardiac status and second malignant neoplasms (SMN) in doxorubicin-treated patients with osteosarcoma (OS).. Platform presentation, American Society of Clinical Oncology Annual Meeting, Chicago, IL.. 2012 June.
- Womer RB, West DC, Krailo MD, Dickman PS, Pawel BR, Grier HE, Marcus K, Sailer S, Healey JH, Dormans JP, Weiss AR. A randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: A report from the Children's Oncology Group.. Journal of Clinical Oncology. Vol 30. 2012:4148-54.
- van Doorninck John A, Ji Lingyun, Schaub Betty, Shimada Hiroyuki, Wing Michele R, Krailo Mark D, Lessnick Stephen L, Marina Neyssa, Triche Timothy J, Sposto Richard, Womer Richard B, Lawlor Elizabeth R. Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Vol 28(12) . 2010 Apr:1989-94.
- Chou Alexander J, Kleinerman Eugenie S, Krailo Mark D, Chen Zhengjia, Betcher Donna L, Healey John H, Conrad Ernest U, Nieder Michael L, Weiner Michael A, Wells Robert J, Womer Richard B, Meyers Paul A,. Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group.. Cancer. Vol 115(22) . 2009 Nov:5339-48.